Home › Rhabdomyosarcoma › Washington › Seattle
Rhabdomyosarcoma clinical trials in Seattle, WA
3 studies for Rhabdomyosarcoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
RecruitingPhase 3
- Seattle Children's Hospital, Seattle
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
RecruitingPhase 1/2
- Seattle Children's, Seattle
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
RecruitingPhase 1
- Seattle Children's Hospital, Seattle
Rhabdomyosarcoma trials in other cities
- Houston, TX6 studies
- Memphis, TN6 studies
- Washington, DC5 studies
- Philadelphia, PA4 studies
- Boston, MA4 studies
- Salt Lake City, UT4 studies
- Baltimore, MD3 studies
- Dallas, TX3 studies
- Birmingham, AL3 studies
- The Bronx, NY3 studies
- Aurora, CO3 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.